---
figid: PMC12066790__41392_2025_2197_Fig4_HTML
figtitle: Oncogenic mechanisms of HBV and HCV in hepatocellular carcinoma
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12066790
filename: 41392_2025_2197_Fig4_HTML.jpg
figlink: /pmc/articles/PMC12066790/figure/F4/
number: F4
caption: 'Oncogenic mechanisms of HBV and HCV in hepatocellular carcinoma. a HBV infection
  causes chromosomal abnormalities, mitotic defects, and increased genetic mutations.
  b HBx activates glycolysis via the NF-κB/HK2 pathway, and excess lactic acid enhances
  HCC proliferation through the PI3K/AKT pathway. c HBV evades T cell responses by
  enhancing the expression of PD-L1 in HCC cells, and its related factors construct
  an inflammatory microenvironment while the infection leads to ROS accumulation and
  triggers oxidative stress. d HBV promotes angiogenesis in HCC by increasing HIF-1α,
  HMGB1, and VEGF expression, and activates MAPK pathways to facilitate metastasis.
  e HBx protein upregulates p65 and HK2, downregulates TXNIP to enhance host cell
  glycolysis. f HCV promotes HCC proliferation by inhibiting EGFR degradation, activating
  Wnt/β-catenin signaling, inducing c-Myc and cyclin D1 expression, blocking K+ channels,
  and enhancing the expression of abnormal DNA polymerase. g HCV suppresses IFN signaling,
  promotes TGF-β1 secretion, and increases inhibitory receptor expression on immune
  cells, thereby dampening the immune response. h HCV infection enriches inflammatory
  factors in the TME, contributing to liver fibrosis. i HCV can enhance glycolysis,
  increase the accumulation of long-chain fatty acids, and interfere with insulin
  signaling. Blue part: HBV carcinogenic mechanism; Red part: HCV carcinogenic mechanism;
  Text in virus color: viral components; Black text: host cell components; Direct
  oncogenesis: a, b (HBV), f (HCV); Indirect oncogenesis: c, d (HBV), g–i (HCV). This
  figure was created with BioRender.com'
papertitle: 'Viral oncogenesis in cancer: from mechanisms to therapeutics'
reftext: Qing Xiao, et al. Signal Transduct Target Ther. 2025;10(NA).
year: '2025'
doi: 10.1038/s41392-025-02197-9
journal_title: Signal Transduction and Targeted Therapy
journal_nlm_ta: Signal Transduct Target Ther
publisher_name: Nature Publishing Group
keywords: Tumour virus infections | Oncogenes
automl_pathway: 0.9499184
figid_alias: PMC12066790__F4
figtype: Figure
redirect_from: /figures/PMC12066790__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12066790__41392_2025_2197_Fig4_HTML.html
  '@type': Dataset
  description: 'Oncogenic mechanisms of HBV and HCV in hepatocellular carcinoma. a
    HBV infection causes chromosomal abnormalities, mitotic defects, and increased
    genetic mutations. b HBx activates glycolysis via the NF-κB/HK2 pathway, and excess
    lactic acid enhances HCC proliferation through the PI3K/AKT pathway. c HBV evades
    T cell responses by enhancing the expression of PD-L1 in HCC cells, and its related
    factors construct an inflammatory microenvironment while the infection leads to
    ROS accumulation and triggers oxidative stress. d HBV promotes angiogenesis in
    HCC by increasing HIF-1α, HMGB1, and VEGF expression, and activates MAPK pathways
    to facilitate metastasis. e HBx protein upregulates p65 and HK2, downregulates
    TXNIP to enhance host cell glycolysis. f HCV promotes HCC proliferation by inhibiting
    EGFR degradation, activating Wnt/β-catenin signaling, inducing c-Myc and cyclin
    D1 expression, blocking K+ channels, and enhancing the expression of abnormal
    DNA polymerase. g HCV suppresses IFN signaling, promotes TGF-β1 secretion, and
    increases inhibitory receptor expression on immune cells, thereby dampening the
    immune response. h HCV infection enriches inflammatory factors in the TME, contributing
    to liver fibrosis. i HCV can enhance glycolysis, increase the accumulation of
    long-chain fatty acids, and interfere with insulin signaling. Blue part: HBV carcinogenic
    mechanism; Red part: HCV carcinogenic mechanism; Text in virus color: viral components;
    Black text: host cell components; Direct oncogenesis: a, b (HBV), f (HCV); Indirect
    oncogenesis: c, d (HBV), g–i (HCV). This figure was created with BioRender.com'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TP53
  - TP63
  - TP73
  - GCK
  - MAP4K2
  - FAM20C
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - FAS
  - FASN
  - TGFB1
  - TGFB2
  - TGFB3
  - TNF
  - STAT3
  - MYC
  - JUN
  - DNMT1
  - AFP
  - TRIM26
  - MMUT
  - SMC5
  - SMC6
  - PPARA
  - RB1
  - IL1A
  - IL6
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - AIFM1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CDK2
  - SOAT1
  - STAT1
  - STAT2
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - NFKB1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - HCC
  - HYCC1
  - CCL2
  - CSF3
  - CTNNB1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - CD274
  - HAVCR2
  - CTLA4
  - KLRK1
  - IFNA1
  - EGFR
  - RAF1
  - ARHGAP24
  - HIF1A
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - AKT1
  - AKT2
  - AKT3
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - HMGB1
  - HK2
  - KCNA5
  - KIF2A
  - KLK2
  - HOOK2
  - TXNIP
  - TERT
  - Glucose
  - NS5A
  - TCA
  - Nucleus
  - ROS
  - Pyruvate
  - cancer
---
